|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1998-2-11
|
|
pubmed:abstractText |
Systemic injection of antigen is one of the approaches that reproducibly induces effective antigen-specific hyporesponsiveness. Here, Roland Liblau and colleagues discuss the cellular and molecular bases of such tolerance, review the current use of this therapeutic strategy in experimental organ-specific autoimmune diseases and analyse what steps are necessary to make this approach suitable for clinical use.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0167-5699
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
599-604
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9425739-Animals,
pubmed-meshheading:9425739-Antigens,
pubmed-meshheading:9425739-Autoimmune Diseases,
pubmed-meshheading:9425739-Diabetes Mellitus, Type 1,
pubmed-meshheading:9425739-Encephalomyelitis, Autoimmune, Experimental,
pubmed-meshheading:9425739-Humans,
pubmed-meshheading:9425739-Immune Tolerance,
pubmed-meshheading:9425739-Immunotherapy,
pubmed-meshheading:9425739-Lymphocyte Depletion,
pubmed-meshheading:9425739-Mice,
pubmed-meshheading:9425739-Mice, Inbred NOD,
pubmed-meshheading:9425739-Mice, Transgenic,
pubmed-meshheading:9425739-T-Lymphocytes
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Systemic antigen in the treatment of T-cell-mediated autoimmune diseases.
|
|
pubmed:affiliation |
Cellular Immunology Laboratory, Hôpital Salpêtrière, Paris, France. 106063.1005@compuserve.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review,
Research Support, Non-U.S. Gov't
|
